Redwingtom
Progressive filth
Posts: 51,857
Joined: Dec 2003
Reputation: 984
I Root For: B-G-S-U !!!!
Location: Soros' Basement |
RE: Nearly 100,000 in U.S. Died from Coronavirus in Biden’s* First Month in Office
(03-04-2021 01:25 PM)MemTigers1998 Wrote: (03-04-2021 01:04 PM)Redwingtom Wrote: Daily doses administered for the week:
Monday, March 1st: 1,663,984
Tuesday, March 2nd: 1,731,614
Wednesday, March 3rd: 1,908,873
7-day rolling average tops 2M for the first time: 2,010,790
https://www.nytimes.com/interactive/2020...doses.html
Muh plateau.
Just imagine how far behind things would be had Trump not been the one pushing for the vaccine. Biden* and Obama couldn't even run the government equivalent of used car lot with Cash for Clunkers. No way the drooling senile pedophile gets vaccines pushed thru like DJT.
This argument is so ******* stupid. Tell me exactly what did trump do to make these companies develop vaccines any faster than they would have under any president?
You honestly believe that trump was somehow alone in pushing for the expedited development of a vaccine? We lost over 500k in America alone. It was a pressing matter dude.
And the reasons why they were developed faster are myriad. From global collaboration to volunteers submitting to trials at levels never before seen.
Yes, Operation Warp Speed was a success...mainly because it was left to professionals and not trump nor Pence. But to pretend that only trump got us here is laughable at best.
Here's some of the reasons for the speed. None of which had much of anything to do with trump...
Quote:Researchers were not starting from scratch when they learned about SARS-CoV-2, the virus that causes COVID-19.
SARS-CoV-2 is a member of the coronavirus family. According to the National Institute of Allergy and Infectious Diseases, there are hundreds of coronaviruses — including four that can cause the common cold, as well as the coronaviruses that sparked the SARS, or severe acute respiratory syndrome, epidemic in 2002 and the emergence of MERS, or Middle East respiratory syndrome, in 2012.
Dr. Eric J. Yager, an associate professor of microbiology at Albany College of Pharmacy and Health Sciences in Albany, NY, told MNT that scientists have been studying coronaviruses for over 50 years. This meant scientists had existing data on the structure, genome, and life cycle of this type of virus.
Quote:Under normal circumstances, making a vaccine can take up to 10–15 years. This is because of the complexity of vaccine development.
Dr. Michael Parry, the chair of Infectious Diseases at Stamford Health in Stamford, CT, told MNT that vaccines train our immune system to remember an infectious agent — without our having to contract it.
“Traditionally, they have contained weakened or inactivated parts of a particular virus (antigen) to trigger an immune response within the body. These vaccines will prompt the immune system to respond, much as it would have on its first reaction to the actual pathogen.”
However, amid a global pandemic, time was a luxury the world could not afford. Researchers quickly mobilized to share their coronavirus data with other scientists.
Dr. Yager said that thanks to advances in genomic sequencing, researchers successfully uncovered the viral sequence of SARS-CoV-2 in January 2020 — roughly 10 days after the first reported pneumonia cases in Wuhan, China. The ability to fast-track research and clinical trials was a direct result of this worldwide cooperation.
Quote:In the U.S., Operation Warp Speed (OWS) partnered with multiple institutions, including the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), to develop, manufacture, and distribute 300 million doses by early next year.
“By providing resources and assuming the financial risk, OWS allows companies to produce and stockpile vaccine doses even before the company knows if the vaccine is going to work,” said Dr. Yager.
“Also, by investing in multiple companies and vaccine platforms at once, OWS increased the odds of having a vaccine, or vaccines, available by the beginning of 2021,” he added.
The European Commission have also funded several vaccine candidates and worked with others in pledging $8 billion for COVID-19 research.
The UK government Vaccine Taskforce have also been a significant contributor to a wide variety of vaccine research. Recipients of this funding helped develop the Oxford/AstraZeneca vaccine. The designers of this vaccine were the first to publish peer reviewed efficacy results from phase 3 trials.
Quote:Dr. Yager said that a major factor behind the rapid completion of clinical trials was a high interest in volunteers for vaccine studies. This helped enrollment goals for reaching thousands of people relatively quickly.
Another factor was the increased number of testing sites to facilitate enrollment and to collect large amounts of data.
How did we develop a COVID-19 vaccine so quickly?
(This post was last modified: 03-04-2021 03:05 PM by Redwingtom.)
|
|
/
[NEWS] Nearly 100,000 in U.S. Died from Coronavirus in Biden’s* First Month in Office
) can be attributed to weekend statistical lags in reporting and the huge winter storm that gripped nearly the entire middle section of our country.![[Image: warning_26a0-fe0f.png]](https://emojipedia-us.s3.dualstack.us-west-1.amazonaws.com/thumbs/120/apple/271/warning_26a0-fe0f.png)
